Forte Biosciences Inc. (FBRX)

Prev Close 37.64
Day Low/High 36.55 / 39.66
52 Wk Low/High 13.35 / 53.99
Exchange NASDAQ
Shares Outstanding 13.51B
Market Cap 508.47M
P/E Ratio N/A
Div & Yield N.A. (N.A)

Quite a few stocks are fading right now -- not due to poor fundamentals, but due to lack of buying interest.

Study those charts and be ready to act as things develop.

Forte's sole clinic candidate is FB-401 for the treatment of atopic dermatitis, which is the scientific name for eczema.

While I remain quite bullish, I am trying to strategize a bit to deal with whatever might hide in the waning days of the year.

As this healthy bounce boosts the market, I'm seeing opportunities in these special purpose acquisition companies.